Search research articles
Contact Us
Filters
Showing results (451-460 of 583) with videos related to
Page
of 59
Sort By:
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
November 3, 2025
Development of a feasible and portable electronic flag for near-real-time identification of renal replacement therapy in the Veterans Health Administration
Samuel W Golenbock, Dipandita Basnet, Hillary J Mull, et al.
Substance Use : Research and Treatment
|
January 26, 2026
Overcoming Challenges to Remote Biochemical Verification of Smoking Status: Insights From Participant Interviews
Margarita Santiago-Torres, Kristin E Mull, Brianna M Sullivan, et al.
American Journal of Human Genetics
|
February 11, 2003
Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia
Math P Cuajungco, Maire Leyne, James Mull, et al.
Journal of the American College of Surgeons
|
September 28, 2010
Validity of selected Patient Safety Indicators: opportunities and concerns
Haytham M A Kaafarani, Ann M Borzecki, Kamal M F Itani, et al.
Nuklearmedizin. Nuclear Medicine
|
April 1, 1995
[Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings]
O Sabri, D Hellwig, H J Kaiser, et al.
Brain and Behavior
|
April 19, 2016
Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?
Friederike Werheid, Hamid Azzedine, Eva Zwerenz, et al.
American Journal of Surgery
|
May 4, 2017
Detection and potential consequences of intraoperative adverse events: A pilot study in the veterans health administration
Qi Chen, Brad S Oriel, Amy K Rosen, et al.
American Journal of Medical Genetics. Part A
|
April 11, 2003
Identification of the first non-Jewish mutation in familial Dysautonomia
Maire Leyne, James Mull, Sandra P Gill, et al.
Genomics
|
February 10, 1995
The human gene for neurotrophic tyrosine kinase receptor type 2 (NTRK2) is located on chromosome 9 but is not the familial dysautonomia gene
S A Slaugenhaupt, A Blumenfeld, C B Liebert, et al.
Psychological Services
|
April 21, 2022
Does screening for PTSD lead to VA mental health care? Identifying the spectrum of initial VA screening actions
Michelle J Bovin, Jack Resnik, Amy M Linsky, et al.
Page
of 59
Search research articles
Search
Showing results (451-460 of 583) with videos related to
Sort By:
Page
of 59
Antimicrobial Stewardship & Healthcare Epidemiology : ASHE
|
November 3, 2025
Development of a feasible and portable electronic flag for near-real-time identification of renal replacement therapy in the Veterans Health Administration
Samuel W Golenbock, Dipandita Basnet, Hillary J Mull, et al.
Substance Use : Research and Treatment
|
January 26, 2026
Overcoming Challenges to Remote Biochemical Verification of Smoking Status: Insights From Participant Interviews
Margarita Santiago-Torres, Kristin E Mull, Brianna M Sullivan, et al.
American Journal of Human Genetics
|
February 11, 2003
Tissue-specific reduction in splicing efficiency of IKBKAP due to the major mutation associated with familial dysautonomia
Math P Cuajungco, Maire Leyne, James Mull, et al.
Journal of the American College of Surgeons
|
September 28, 2010
Validity of selected Patient Safety Indicators: opportunities and concerns
Haytham M A Kaafarani, Ann M Borzecki, Kamal M F Itani, et al.
Nuklearmedizin. Nuclear Medicine
|
April 1, 1995
[Effect of morphological changes on perfusion and metabolism in cerebral microangiopathy. A comparison of PET, SPECT, and magnetic resonance imaging findings]
O Sabri, D Hellwig, H J Kaiser, et al.
Brain and Behavior
|
April 19, 2016
Underestimated associated features in CMT neuropathies: clinical indicators for the causative gene?
Friederike Werheid, Hamid Azzedine, Eva Zwerenz, et al.
American Journal of Surgery
|
May 4, 2017
Detection and potential consequences of intraoperative adverse events: A pilot study in the veterans health administration
Qi Chen, Brad S Oriel, Amy K Rosen, et al.
American Journal of Medical Genetics. Part A
|
April 11, 2003
Identification of the first non-Jewish mutation in familial Dysautonomia
Maire Leyne, James Mull, Sandra P Gill, et al.
Genomics
|
February 10, 1995
The human gene for neurotrophic tyrosine kinase receptor type 2 (NTRK2) is located on chromosome 9 but is not the familial dysautonomia gene
S A Slaugenhaupt, A Blumenfeld, C B Liebert, et al.
Psychological Services
|
April 21, 2022
Does screening for PTSD lead to VA mental health care? Identifying the spectrum of initial VA screening actions
Michelle J Bovin, Jack Resnik, Amy M Linsky, et al.
Page
of 59